The Norovirus Test Kit Market is expanding as the demand for rapid and accurate detection of norovirus infections increases across healthcare and public health settings. Norovirus is a major cause of acute gastroenteritis, making reliable diagnostic tools important for identifying infections and managing outbreaks. According to WiseGuyReports, the global market was valued at approximately USD 1 billion in 2025 and is projected to reach USD 2 billion by 2035, growing at a CAGR of 9.3%.
The rising incidence of norovirus outbreaks is one of the primary factors driving market development. Hospitals, diagnostic laboratories, public health agencies, and research institutions increasingly require efficient testing solutions for outbreak investigation and patient management.
Technological advancements are also influencing the market. Molecular diagnostic techniques, including real-time PCR, are improving sensitivity and accuracy while helping reduce turnaround times. Rapid antigen tests are gaining attention because they can provide results more quickly than conventional laboratory procedures.
The market is segmented by test type, application, end use, sample type, and region. Molecular tests, antigen tests, and serological tests serve different diagnostic requirements, while fecal, environmental, and food samples support clinical and surveillance applications.
North America is expected to remain a leading regional market, while Asia-Pacific is anticipated to experience significant growth because of increasing healthcare initiatives and awareness of food safety. Overall, technological innovation and the growing need for rapid outbreak management are expected to support continued market expansion.